产品名称 | NebuSelect™ Recombinant Human FCRL2/IRTA4, His-tag |
---|---|
目录号 | NBL-241789 |
别名 | FCRL2/IRTA4; FcR-like protein 2; FcRL2; FCRH2; IFGP4; IRTA4; FCRL2; CD307b; FCRH2SPAP1B; IRTA4SPAP1C; SPAP1; SPAP1A |
外观 | see COA |
分子量 | Leu20-Val401 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q96LA5-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241789-100ug | 100ug | Inquire | Inquire | |
NBL-241789-1mg | 1mg | Inquire | Inquire | |
NBL-241789-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human FCRL2/IRTA4, His-tag
Catalog#:
NBL-241789
Description:
NebuSelect™ Recombinant Human FCRL2/IRTA4, His-tag(Cat#NBL-241789) is expressed in HEK293 with His tag at the C-Terminus.It contains Leu20-Val401.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 42.7 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Target Name:
FCRL2/IRTA4; FcR-like protein 2; FcRL2; FCRH2; IFGP4; IRTA4; FCRL2; CD307b; FCRH2SPAP1B; IRTA4SPAP1C; SPAP1; SPAP1A
Target Information:
Fc receptor-like 2 (FCRL2) is highly expressed on B-cell chronic lymphocytic leukemia (B-CLL) cells and could possibly influence disease pathogenesis. FCRL2 mRNA expression was found to be expressed at considerably higher levels in peripheral blood mononuclear cells (PBMC) of B-CLL patients compared to controls (range 1.35- to 210-fold upregulation; P < 0.0001) and cells of other hematological diseases.
Amino Acid Sequence:
Leu20-Val401
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.